Chiasma, Inc

Short Term Long Term Short Term Comparison Long Term Comparison
  • CHMA
  • 1d-6.00%
  • 1w-6.93%
  • 1m-16.07%
  • 1y-21.67%
ATH
  • ATH Price$28.64
  • ATH Date2015-09-09
  • % since ATH-86.87%
  • % to ATH661.70%
ATL
  • ATL Price$1.25
  • ATL Date2017-08-02
  • % from ATL200.80%
  • Last Low Price$1.25
  • Last Low Date2017-08-02
  • % From Last Low200.80%
IPO
  • IPO Price$16.00
  • % Current ROI USD-76.50%
  • ATH Price$28.64
  • % ROI ATH 229,120.00%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="CHMA"]

Key Data [addtoany]

Current price $3.76
Sector Healthcare
Industry Biotechnology
Today's High/Low $4.1/$3.76
Volume 8,050,379.00
Previous Close $4
52 Week High/Low $5.74/$2.77
Market Cap 237,810,224.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $-0.71
Annualized Dividend $0
$3.76
[addtoany]

Chiasma, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide.
The company offers MYCAPSSA, an oral octreotide capsule for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide.
It also develops MPOWERED, an oral octreotide capsule, which has completed Phase III clinical trials for the maintenance treatment of adult patients with acromegaly. Chiasma, Inc. was incorporated in 2001 and is headquartered in Needham, Massachusetts.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity